D-0350-2026 Class II Ongoing
FDA drug recall D-0350-2026 was initiated by Wizcure Pharmaa Private Limited on Dec 31, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. The recall status is ongoing. Affected quantity: 10,080 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 4, 2026
- Initiation Date
- Dec 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,080 boxes
Product description
CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,
Reason for recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Distribution pattern
Distributed Nationwide in the USA
Code information
All lots
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0350-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026